Skip to main content

more options


Physician: Ronald G. Crystal, M.D.

Dr. Ronald G. Crystal

New York-Presbyterian Hospital/The Weill Medical College of Cornell University
Division of Pulmonary and Critical Care Medicine

520 East 70th Street
Starr Building, Suite 505
New York, NY 10021
phone: 212-746-2250
fax: 212-746-8808

Education:
M.D.  University of Pennsylvania, Philadelphia, PA
M.S.  University of Pennsylvania, Philadelphia, PA
B.A.  (cum laude) Tufts University, Medford, MA

Post-doctoral Training:
Internship:Internal Medicine, Massachusetts General Hospital,
 Boston, MA

Residency: Internal Medicine, Massachusetts General Hospital, Boston, MA

Fellowship: Clinical Fellow in Medicine, Harvard University,
 Cambridge, MA


Academic Positions:
Chairman, Department of Genetic Medicine, Weill Medical
 College of Cornell University, New York, NY

Bruce Webster Professor of Internal Medicine and Professor of
 Genetic Medicine, Weill Medical College of Cornell University,
 New York, NY

Director, The Arthur and Rochelle Belfer Gene Therapy Core
 Facility, Weill Medical College of Cornell University,
 New York, NY

Professor of Physiology, Biophysics, Molecular Medicine, Weill
 Graduate School of Medical Sciences, Weill Medical College of
 Cornell University, New York, NY

Adjunct Professor and Visiting Physician, The Rockefeller
 University, New York, NY

Hospital Appointments:
Chief, Division of Pulmonary and Critical Care Medicine,
 Department of Medicine, New York Weill Cornell Medical
 Center, New York-Presbyterian Hospitals, New York, NY

Attending Physician, New York Presbyterian Hospital-Weill
 Cornell Medical Center, New York, NY

New York-Presbyterian Hospital Consultant, Department of
 Medicine/Pulmonary Diseases, Hospital for Special Surgery,
 New York, NY

Board Certifications:
Diplomat of the National Board of Medical Examiners (1969)

Diplomat of the American Board of Internal Medicine (1974)

Diplomat in Pulmonary Disease, American Board of Internal
 Medicine (1974)


Honors and Awards

Grants

Scientific Publications:
  • Amano H, Hackett NR, Kaner RJ, Whitlock P, Crystal RG. Alteration of splicing signals in a genomic/cDNA hybrid VEGF gene to modify the ratio of expressed VEGF isoforms enhances potency and safety of angiogenic gene therapy. Mol Ther 2005: 12:716-724.
  • Hashimoto M, Boyer JL, Hackett NR, Wilson JM, Crystal RG. Induction of protective immunity to anthrax lethal toxin with a non-human primate adenovirus-based vaccine in the presence of pre-existing anti-human adenovirus immunity. Infec Immun 2005; 73: 6885-6891.
  • Arkin LM, Sondhi D, Worgall S, Suh LHK, Hackett NR, Kaminsky SM, Hosain SA, Souweidane MM, Kaplitt MG, Dyke JP, Heier LA, Ballon DJ, Shungu DC, Wisniewski KE, Greenwald BM, Hollmann C, Crystal RG. Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders. Hum Gene Ther 2005; 16: 1028-1036.
  • Amano H, Hackett NR, Rafii S, Crystal RG. Thrombopoietin gene transfer-mediated enhancement of angiogenic responses to acute ischemia. Circ Res 2005; 97: 337-345.
  • Mae M, O'Connor TP, Crystal RG. Adenovirus-mediated gene transfer and expression of a truncated soluble form of the vascular endothelial growth factor receptor flt-1 suppresses the accelerated development of pulmonary metastasis associated with post-pneumonectomy lung growth. Am J Respir Cell Mol Biol 2005; 33: 629-635.
  • [Read More]